In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The price of Aspen Aerogels Inc (NYSE: ASPN) closed at $6.35 in the last session, up 2.09% from day before closing price of $6.22. In other words, the price has increased by $2.09 from its previous closing price. On the day, 2.02 million shares were traded. ASPN stock price reached its highest trading level at $6.435 during the session, while it also had its lowest trading level at $6.01.
Ratios:
We take a closer look at ASPN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.53 and its Current Ratio is at 4.22. In the meantime, Its Debt-to-Equity ratio is 0.57 whereas as Long-Term Debt/Eq ratio is at 0.50.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 12 ’25 when Young Donald R bought 20,000 shares for $5.35 per share. The transaction valued at 107,000 led to the insider holds 550,856 shares of the business.
Young Donald R sold 63,355 shares of ASPN for $1,902,551 on Sep 30 ’24. The President and CEO now owns 483,640 shares after completing the transaction at $30.03 per share. On Sep 30 ’24, another insider, Donald R. Young, who serves as the President, CEO, Director of the company, bought 134,629 shares for $27.62 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ASPN now has a Market Capitalization of 521807424 and an Enterprise Value of 510653184. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.19 while its Price-to-Book (P/B) ratio in mrq is 1.66. Its current Enterprise Value per Revenue stands at 1.169 whereas that against EBITDA is -2.425.
Stock Price History:
The Beta on a monthly basis for ASPN is 2.70, which has changed by -0.7655096 over the last 52 weeks, in comparison to a change of 0.11936104 over the same period for the S&P500. Over the past 52 weeks, ASPN has reached a high of $33.15, while it has fallen to a 52-week low of $4.16. The 50-Day Moving Average of the stock is 6.35%, while the 200-Day Moving Average is calculated to be -56.52%.
Shares Statistics:
According to the various share statistics, ASPN traded on average about 1.95M shares per day over the past 3-months and 3475950 shares per day over the past 10 days. A total of 82.17M shares are outstanding, with a floating share count of 80.69M. Insiders hold about 1.81% of the company’s shares, while institutions hold 88.47% stake in the company. Shares short for ASPN as of 1745971200 were 8386150 with a Short Ratio of 4.30, compared to 1743379200 on 9201628. Therefore, it implies a Short% of Shares Outstanding of 8386150 and a Short% of Float of 12.2.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The current rating of Aspen Aerogels Inc (ASPN) reflects the combined expertise of 2.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is -$0.08, with high estimates of -$0.05 and low estimates of -$0.13.
Analysts are recommending an EPS of between -$0.35 and -$0.35 for the fiscal current year, implying an average EPS of -$0.35. EPS for the following year is $0.34, with 4.0 analysts recommending between $0.84 and -$0.07.
Revenue Estimates
According to 7 analysts, the current quarter’s revenue is expected to be $72.53M. It ranges from a high estimate of $74.7M to a low estimate of $70.36M. As of the current estimate, Aspen Aerogels Inc’s year-ago sales were $117.77MFor the next quarter, 7 analysts are estimating revenue of $68.33M. There is a high estimate of $72.3M for the next quarter, whereas the lowest estimate is $64.1M.
A total of 7 analysts have provided revenue estimates for ASPN’s current fiscal year. The highest revenue estimate was $302.6M, while the lowest revenue estimate was $280.2M, resulting in an average revenue estimate of $292.02M. In the same quarter a year ago, actual revenue was $452.7MBased on 7 analysts’ estimates, the company’s revenue will be $371.13M in the next fiscal year. The high estimate is $419.3M and the low estimate is $335.8M.
